WHO: Moffitt Cancer Center and the American Association for Cancer Research (AACR), with support from U.S. Representatives Gus Bilirakis and Kathy Castor, the Association of American Cancer Institutes, and featuring National Cancer Institute Acting Director Douglas R. Lowy, M.D.
WHAT: Moffitt and the AACR are hosting Cancer Research Policy Forum: Progress, Promise and Challenges in the Era of Precision Medicine. The event will describe how federally funded research is contributing to the groundbreaking cancer research happening at Moffitt and other institutions across the United States. A group of expert panelists will discuss progress being made in cancer research and treatment, the importance of robust and predictable increases in funding for the National Institutes of Health, as well as special initiatives such as the national cancer initiative to be led by Vice-President Biden, and the Administration’s Precision Medicine Initiative.
- Douglas R. Lowy, M.D., National Cancer Institute (NCI) Acting Director
- U.S. Rep. Gus Bilirakis (R), 12th Congressional District of Florida
- U.S. Rep. Kathy Castor (D), 14th Congressional District of Florida
- Alan F. List, M.D., Moffitt President & CEO
- Thomas A. Sellers, Ph.D., M.P.H., Moffitt Center Director
- William S. Dalton, Ph.D., M.D., M2Gen CEO, and Chair, AACR Science Policy & Government Affairs Committee
- Jon Retzlaff, M.B.A., M.P.A., AACR Managing Director of Science Policy & Government Affairs
- Jacqueline Smith, melanoma cancer survivor treated at Moffitt Cancer Center
Attendees will be invited to participate in a question and answer session following the program.
The forum is free and open to the public.
WHEN: Monday, March 7, 10-11:30 a.m.
WHERE: Moffitt Cancer Center, Vincent A. Stabile Research Building, 12902 Magnolia Drive, Tampa, Fla. 33612
CONTACT: To RSVP for the forum, please email PolicyForum@moffitt.org.
About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. One of the three largest cancer centers in the United States based on patient volume, the Tampa-based facility is one of only 45 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the top-ranked cancer hospital in Florida and has been listed in U.S. News & World Report as one of the “Best Hospitals” for cancer care since 1999. Moffitt devotes more than 2 million square feet to research and patient care. With more than 5,000 team members, Moffitt has an economic impact in the state of $1.9 billion. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the Moffitt momentum on Facebook, Twitter and YouTube.
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 35,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and patient advocates residing in 101 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis, and treatment of cancer by annually convening more than 30 conferences and educational workshops, the largest of which is the AACR Annual Meeting with nearly 19,300 attendees. In addition, the AACR publishes eight prestigious, peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual investigator grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and other policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit www.AACR.org.